Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma

Urology

Volumn 60, Issue 4, 2002, Pages 666-669

  Rioux Leclercq, Nathalie C ^a   Chan, David Y ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL PROTOCOL; DISEASE COURSE; FOLLOW UP; HEALTH STATUS; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARAMETER; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; RATING SCALE; RISK FACTOR; SCREENING; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOCARCINOMA; AGED; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0036774203     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01816-2     Document Type: Article

References (16)

1. Wingo P.A., Ries L.A., Parker S.L., et al. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev. 7:1998;271-282.
2. Lu-Yao G.L., McLerran D., Wasson J., et al. for the Prostate Patient Outcomes Research Team . An assessment of radical prostatectomy time trends, geographic variation, and outcomes . JAMA. 269:1993;2633-2636.
3. Potosky A.L., Miller B.A., Albertsen P.C., et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 273:1995;548-552.
4. Epstein J.I., Partin A.W., Sauvageot J., et al. Prediction of progression following radical prostatectomy a multivariate analysis of 721 men with long-term follow-up . Am J Surg Pathol. 20:1996;286-292.
5. Oefelein M.G., Grayhack J.T., McVary K.T., et al. Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer. 76:1995;2535-2542.
6. Ohori M., Goad J.R., Wheeler T.M., et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol. 152:1994;1843-1849.
7. Lau W.K., Bergstralh E.J., Blute M.L., et al. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer influence of concomitant pathological variables . J Urol. 167:2002;117-122.
8. Partin A.W., Epstein J.I., Cho K.R., et al. Morphometric measurement of tumor volume and percent of glandular involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol. 141:1989;341-345.
9. Epstein J.I., Pizov G., Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 71:1993;3582-3593.
10. Oefelein M.G., Smith N.D., Grayhack J.T., et al. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol. 158:1997;1460-1465.
11. Chan T.Y., Partin A.W., Walsh P.C., et al. The prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology. 56:2000;823-827.
12. Epstein J.I., Pound C.R., Partin A.W., et al. Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol. 160:1998;97-101.
13. Do T.M., Parker R.G., Smith R.B., et al. High-grade carcinoma of the prostate a comparison of current local therapies . Urology. 57:2001;1121-1126.
14. Partin A.W., Lee B.R., Carmichael M., et al. Radical pros-tatectomy for high grade disease a re-evaluation 1993 . J Urol. 151:1994;1583-1586.
15. Blute M.L., Nativ O., Zincke H., et al. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate influence of tumor deoxyribonucleic acid ploidy . J Urol. 142:1989;1262-1265.
16. Epstein J.I., Carmichael M., Partin A.W., et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow-up. J Urol. 149:1993;1478-1481.